A detailed history of True Wealth Design, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, True Wealth Design, LLC holds 148 shares of NVO stock, worth $15,548. This represents 0.01% of its overall portfolio holdings.

Number of Shares
148
Previous 351 57.83%
Holding current value
$15,548
Previous $50.1 Million 64.83%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $24,171 - $29,520
-203 Reduced 57.83%
148 $17.6 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $28,836 - $34,523
235 Added 202.59%
351 $50.1 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $4,697 - $6,252
46 Added 65.71%
116 $14.9 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $2,910 - $6,385
32 Added 84.21%
70 $6.37 Million
Q4 2022

Feb 15, 2023

BUY
$102.55 - $135.33 $3,896 - $5,142
38 New
38 $5.14 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.